Chinese Peptide Company: difference between revisions
Diff·revision 59 → 60·11:00, 20 Jul 2025
Difference between revision 59 and revision 60 of Chinese Peptide Company. 7 lines changed; the page grew by 1,024 bytes.
| Revision 59 — 00:20, 13 Jul 2025 VerifyFirstVida (talk) fix significant figures — source gives fewer 10,666 bytes ±0 | Revision 60 — 11:00, 20 Jul 2025 BetaCellBoyd (talk) correct percentage: source reports placebo-adjusted 11,690 bytes +1,024 | ||
|---|---|---|---|
| 75 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} | 75 | Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} |
| 76 | 76 | ||
| + | 77 | Import of such material for personal use is unlawful or restricted in many jurisdictions, and [[Customs seizure|seizure]] is a documented outcome. PeptidePedia describes the legal position and does not advise on it.{{r|ruo}} | |
| + | 78 | ||
| + | 79 | == Notability and coverage == | |
| + | 80 | This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} | |
| + | 81 | ||
| + | 82 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} | |
| + | 83 | ||
| 77 | == References == | 84 | == References == |
| 78 | {{reflist}} | 85 | {{reflist}} |